Since 1942, therapy with radioiodine (RIT) has gained a major role in the treatment of
benign thyroid disorders, notably hyperthyroidism caused by Graves' disease or toxic …

Over half a century, treatment of thyroid autonomy with an oral dose of iodine-131 has
proven to be effective. The optimum management strategy for the patient is, however, still a …

In the last decade, several concepts were developed to improve the outcome of radioiodine
therapy for functional thyroid autonomy. These concepts base on Marinellisformula, which …

Aim: The effectiveness of radioiodine therapy (RIT) is proven. The aim of this study was to
determine, how much time passes between diagnosis of thyroid autonomy or occurrence of …

The present study analyzes the improvement of the outcome of radioiodine therapy in non-
immunogenic hyperthyroidism by adapting the target dose to the 99mTc-pertechnetate …

Aim: The presented study examines prospectively the efficiency of a dose concept for
radioiodine therapy (RIT) adapted to the pretherapeutic" mTc-pertechnetate thyroid uptake …

Objective To evaluate the effect of dose rate on the therapeutic success of radioiodine
therapy (RIT) by retrospective analysis of two groups of patients with different dose rates …

Aim The goal of this retrospective study was to evaluate the results of radioiodine therapy of
thyroid autonomy with respect to the underlying scintigraphic pattern, administered I-131 …

The success rate of radioiodine (I-131) therapy for toxic goiter and solitary hyperfunctioning
nodules depends on thyroid volume, compensation of hyperthyroidism, timing of the …

Background High iodine uptake levels are widely accepted as a condition for successful
treatment with radioiodine (RAI). However, the existing data are controversial and the …